EYPT

#2341
EyePoint, Inc. Common Stock
14.3400 USD
-1.24%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
14.3400
14.3400
Intervallo Annuale
9.6500
19.0100
Variazione giornaliera
-1.24%
Variazione Mensile
+6.86%
Variazione di 6 mesi
+19.50%
Variazione Annuale
+19.50%
Chiusura Precedente
14.5200
Apertura
14.3400
Bid
Ask
Minimo
14.3400
High
14.3400
Volume
94
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 1.1964 B
  • Employee 214
  • Founded 2000
  • CEO N/A
  • Website www.eyepoint.bio
  • Headquarter Delaware, United States
  • FIGI BBG000F90JX5
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-5.76
Rapporto prezzo/fatturato
0.04

EyePoint Inc

EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery. pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner. In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc.

Notizie